Intellectual Property Rights (IPR) laws are designed to encourage innovation, creativity, and economic growth by granting creators and inventors exclusive rights over their intellectual creations. However, not every provision within India’s intellectual property framework enjoys universal acceptance. Several laws and legal provisions remain controversial because they attempt to balance competing interests such as private ownership versus public access, innovation versus competition, pharmaceutical patents versus public health, copyright protection versus freedom of expression, and traditional knowledge versus commercialization.
While supporters view these laws as essential for protecting creators and attracting investment, critics argue that some provisions create monopolies, restrict access to knowledge, increase costs for consumers, or fail to adequately protect public interests. India’s IPR regime, which includes the Patents Act, 1970, Copyright Act, 1957, Trade Marks Act, 1999, Geographical Indications of Goods (Registration and Protection) Act, 1999, Protection of Plant Varieties and Farmers’ Rights Act, 2001, and related legislation, contains several provisions that have generated significant legal, economic, and political debate. One of the most controversial provisions in Indian patent law is Section 3(d) of the Patents Act, 1970.
This provision was introduced to prevent “evergreening,” a practice whereby pharmaceutical companies obtain new patents on minor modifications of existing drugs to extend monopoly protection beyond the original patent term. Section 3(d) states that the mere discovery of a new form of a known substance that does not result in enhanced efficacy is not patentable.
The provision gained global attention in the landmark case of Novartis AG v. Union of India (2013), where the Supreme Court denied patent protection for the beta crystalline form of Imatinib Mesylate, a cancer drug marketed as Glivec. Supporters praised the judgment as a victory for affordable healthcare and access to medicines, arguing that it prevented pharmaceutical monopolies from artificially extending patent protection. Critics, however, contended that the provision discourages incremental innovation and may reduce foreign investment in pharmaceutical research. The debate surrounding Section 3(d) continues to influence international discussions on balancing patent rights and public health.
Another controversial aspect of Indian patent law is the compulsory licensing mechanism under Sections 84 and 92 of the Patents Act. Compulsory licensing allows the government or authorized entities to produce patented products without the consent of the patent holder under specific circumstances, such as public health emergencies or when patented products are not available at reasonable prices. The most notable example is Bayer Corporation v. Natco Pharma Ltd. (2012), where India granted its first compulsory license for the anti-cancer drug Nexavar (Sorafenib Tosylate). Natco was permitted to manufacture a generic version at a significantly lower price than Bayer’s patented product. Public health advocates celebrated the decision as a mechanism for improving access to life-saving medicines, while multinational pharmaceutical companies criticized it as undermining patent protection and reducing incentives for innovation. The controversy reflects a broader tension between protecting inventors and ensuring affordable healthcare in developing economies. Another unpopular provision among international businesses is India’s exclusion of software patents under Section 3(k) of the Patents Act.
The provision states that mathematical methods, business methods, computer programs per se, and algorithms are not patentable inventions. India has maintained a restrictive approach toward software patents compared to jurisdictions such as the United States. Advocates argue that software patents can stifle innovation, create barriers for startups, and encourage patent trolling. Critics contend that the exclusion fails to adequately protect technological innovation in an increasingly digital economy. As artificial intelligence, machine learning, blockchain technologies, and software-driven inventions become more important, debates regarding the scope of software patent protection are likely to intensify. Copyright law also contains several controversial provisions. One of the most debated is the extensive duration of copyright protection. Under the Copyright Act, 1957, literary, dramatic, musical, and artistic works are generally protected for the lifetime of the author plus sixty years after death. Critics argue that such lengthy protection periods benefit large corporate rights holders more than individual creators and delay the entry of works into the public domain.
Public domain advocates contend that excessively long copyright terms restrict access to knowledge, culture, and educational materials. Supporters of longer copyright protection argue that it rewards creativity, supports heirs, and incentivizes artistic production. Similar debates exist globally and continue to shape discussions regarding copyright reform. Another controversial issue concerns criminal penalties for copyright infringement. Unlike many jurisdictions where copyright disputes are primarily civil matters, India provides for criminal sanctions under the Copyright Act.
Individuals accused of infringement may face imprisonment and fines in certain circumstances. Supporters argue that criminal enforcement acts as a deterrent against piracy, which causes significant losses to creative industries. Critics contend that criminalizing copyright disputes may be disproportionate, particularly in cases involving small-scale infringement, educational use, or technological innovation. The enforcement of anti-piracy provisions often raises concerns regarding freedom of expression, access to information, and fair use rights. Fair dealing itself remains a controversial area within Indian copyright law. Unlike the broader fair use doctrine recognized in the United States, India’s fair dealing provisions are more limited and apply primarily to research, private study, criticism, review, reporting of current events, and certain educational purposes.
Courts have often been required to balance the interests of copyright owners against public access to information. A notable example is The Chancellor, Masters and Scholars of the University of Oxford v. Rameshwari Photocopy Services (2016), commonly known as the Delhi University Photocopy Case. Academic publishers argued that the reproduction of course materials infringed copyright, while students and educators maintained that educational access should take precedence. The Delhi High Court ultimately favored educational access, but the case highlighted ongoing tensions between intellectual property rights and public interest objectives. Trademark law has generated its own controversies, particularly concerning well-known trademarks and trademark dilution.
Large corporations often seek extensive protection for famous marks, sometimes challenging smaller businesses using similar names or branding. Critics argue that powerful corporations may use trademark law aggressively to suppress competition or intimidate small businesses through costly litigation. The expansion of trademark rights beyond consumer confusion into dilution protection has sparked debate regarding the appropriate scope of trademark monopolies. Another contentious issue concerns non-traditional trademarks such as colors, sounds, shapes, and trade dress. While supporters view such protections as necessary to safeguard brand identity, critics question whether granting exclusive rights over colors, packaging designs, or sounds may excessively restrict market competition. Geographical Indication (GI) protection has also generated controversy.
India has successfully registered numerous GIs, including Darjeeling Tea, Basmati Rice, Kanchipuram Silk, Nagpur Orange, and Alphonso Mango. While GI protection aims to preserve cultural heritage and promote regional economic development, disputes frequently arise regarding ownership, geographical boundaries, and eligibility criteria. The international dispute over Basmati rice provides a notable example. India and Pakistan have both asserted claims regarding the historical and geographical origins of Basmati, illustrating how GI protection can intersect with international trade and national identity. Critics sometimes argue that GI protection may create barriers for producers located outside designated regions, even when they have long histories of producing similar goods. The Protection of Plant Varieties and Farmers’ Rights Act, 2001 is another unique and controversial aspect of India’s IPR framework.
Unlike many countries that prioritize breeders’ rights, India adopted a hybrid approach that also recognizes farmers’ rights. Farmers are permitted to save, use, sow, resow, exchange, share, and sell farm-saved seeds of protected varieties under certain conditions. Agricultural biotechnology companies have often criticized these provisions as limiting commercial incentives for plant breeding innovation. Farmers’ organizations, on the other hand, view the law as essential for preserving traditional agricultural practices and preventing excessive corporate control over seeds. The conflict reflects broader concerns regarding food security, biodiversity, and the rights of indigenous and farming communities. Traditional knowledge protection presents another controversial area. India has invested significant resources in documenting traditional knowledge through initiatives such as the Traditional Knowledge Digital Library (TKDL).
The objective is to prevent biopiracy, where companies seek patents on traditional remedies, medicinal plants, or indigenous knowledge without authorization or benefit-sharing. Famous examples include disputes involving turmeric, neem, and basmati. While many support strong protections against biopiracy, questions remain regarding ownership, benefit-sharing mechanisms, and the extent to which traditional knowledge should be integrated into conventional intellectual property systems. More recently, artificial intelligence has introduced new controversies into India’s IPR landscape. Existing intellectual property laws were drafted with human creators and inventors in mind. As AI systems increasingly generate artistic works, inventions, software code, music, and literary content, legal uncertainty has emerged regarding ownership, authorship, and patentability.
Should AI-generated works receive copyright protection? Can an AI system be recognized as an inventor? Who owns content created by generative AI tools? Indian law currently provides limited answers, creating uncertainty for businesses, creators, and policymakers. Similar debates are occurring worldwide and may require substantial legislative reform in the coming years. In conclusion, India’s intellectual property framework reflects a deliberate effort to balance private rights with public interest objectives. However, this balancing exercise inevitably creates controversy because different stakeholders possess competing interests. Pharmaceutical companies seek stronger patent protection while public health advocates prioritize affordable medicines.
Copyright owners seek robust enforcement while educators and researchers advocate broader access. Technology companies demand greater protection for software innovations while policymakers worry about monopolization. Farmers seek seed sovereignty while breeders seek commercial incentives. These tensions ensure that intellectual property law remains one of the most dynamic and debated areas of legal policy. The controversial provisions within India’s IPR regime are not merely legal technicalities; they reflect broader societal choices regarding innovation, competition, access to knowledge, healthcare, cultural preservation, economic development, and technological progress. As India continues its journey toward becoming a knowledge-driven economy, debates surrounding these unpopular and controversial laws will remain central to the future evolution of intellectual property rights in the country.
Leave a Reply